TFF Pharmaceuticals (TFFP) Competitors $0.06 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TFFP vs. ADXS, EVFM, NMTR, HSTO, PXMD, PTEIQ, SRNE, PKBO, BDRX, and NEXIShould you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include Ayala Pharmaceuticals (ADXS), Evofem Biosciences (EVFM), 9 Meters Biopharma (NMTR), Histogen (HSTO), PaxMedica (PXMD), PolarityTE (PTEIQ), Sorrento Therapeutics (SRNE), Peak Bio (PKBO), Biodexa Pharmaceuticals (BDRX), and NexImmune (NEXI). These companies are all part of the "pharmaceutical products" industry. TFF Pharmaceuticals vs. Ayala Pharmaceuticals Evofem Biosciences 9 Meters Biopharma Histogen PaxMedica PolarityTE Sorrento Therapeutics Peak Bio Biodexa Pharmaceuticals NexImmune Ayala Pharmaceuticals (NASDAQ:ADXS) and TFF Pharmaceuticals (NASDAQ:TFFP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, community ranking, analyst recommendations, dividends, media sentiment and earnings. Do insiders & institutionals believe in ADXS or TFFP? 7.2% of Ayala Pharmaceuticals shares are owned by institutional investors. Comparatively, 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 0.6% of Ayala Pharmaceuticals shares are owned by insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, ADXS or TFFP? TFF Pharmaceuticals has lower revenue, but higher earnings than Ayala Pharmaceuticals. TFF Pharmaceuticals is trading at a lower price-to-earnings ratio than Ayala Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAyala Pharmaceuticals$3.24M0.36-$48.07M-$7.980.00TFF Pharmaceuticals-$70.98K-4.07-$21.24M-$6.44-0.01 Do analysts recommend ADXS or TFFP? TFF Pharmaceuticals has a consensus target price of $44.00, suggesting a potential upside of 67,592.31%. Given TFF Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe TFF Pharmaceuticals is more favorable than Ayala Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ayala Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TFF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, ADXS or TFFP? Ayala Pharmaceuticals has a beta of 1.7, indicating that its stock price is 70% more volatile than the S&P 500. Comparatively, TFF Pharmaceuticals has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Does the media favor ADXS or TFFP? In the previous week, Ayala Pharmaceuticals' average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score. Company Overall Sentiment Ayala Pharmaceuticals Neutral TFF Pharmaceuticals Neutral Does the MarketBeat Community believe in ADXS or TFFP? TFF Pharmaceuticals received 67 more outperform votes than Ayala Pharmaceuticals when rated by MarketBeat users. Likewise, 67.68% of users gave TFF Pharmaceuticals an outperform vote while only 0.00% of users gave Ayala Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAyala PharmaceuticalsOutperform VotesNo VotesUnderperform Votes66100.00% TFF PharmaceuticalsOutperform Votes6767.68% Underperform Votes3232.32% Is ADXS or TFFP more profitable? Ayala Pharmaceuticals has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,596.64%. Ayala Pharmaceuticals' return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ayala PharmaceuticalsN/A N/A N/A TFF Pharmaceuticals -1,596.64%-310.17%-196.06% SummaryTFF Pharmaceuticals beats Ayala Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFFP vs. The Competition Export to ExcelMetricTFF PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$289,000.00$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.0110.5990.0517.18Price / Sales-4.07195.801,117.14116.99Price / CashN/A57.1643.0437.86Price / Book0.025.094.784.78Net Income-$21.24M$151.83M$120.31M$225.60M7 Day PerformanceN/A-2.13%-1.92%-1.23%1 Month PerformanceN/A-3.10%11.51%3.36%1 Year PerformanceN/A11.54%30.61%16.60% TFF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFFPTFF Pharmaceuticals2.1554 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$-70,983.00-0.0119Positive NewsADXSAyala PharmaceuticalsN/A$0.03flatN/A-95.7%$1.15M$10,000.000.0020Analyst ForecastGap UpEVFMEvofem BiosciencesN/A$0.01-1.0%N/A-83.9%$1.09M$11.39M-0.02120Gap UpNMTR9 Meters BiopharmaN/A$0.07-43.0%N/AN/A$1.04MN/A-0.0220Gap DownHigh Trading VolumeHSTOHistogenN/A$0.22+975.0%N/A-91.3%$918,000.00$19,000.00-0.017Gap UpPXMDPaxMedicaN/A$0.08+12.4%N/A-90.3%$890,000.00N/A0.002Gap UpPTEIQPolarityTEN/A$0.08flatN/A+18.1%$615,000.00$810,000.00-0.0460High Trading VolumeSRNESorrento TherapeuticsN/A$0.00-26.7%N/A-96.5%$606,000.00$62.84M0.00800Analyst ForecastGap DownPKBOPeak BioN/A$0.02-67.9%N/A-81.3%$520,000.00$370,000.00-0.143Gap DownHigh Trading VolumeBDRXBiodexa Pharmaceuticals1.5902 of 5 stars$4.27+1.7%$200.00+4,583.8%N/A$508,000.00$83,000.000.0021NEXINexImmuneN/A$0.30+30.4%N/A-89.7%$418,000.00N/A-0.016 Related Companies and Tools Related Companies Ayala Pharmaceuticals Competitors Evofem Biosciences Competitors 9 Meters Biopharma Competitors Histogen Competitors PaxMedica Competitors PolarityTE Competitors Sorrento Therapeutics Competitors Peak Bio Competitors Biodexa Pharmaceuticals Competitors NexImmune Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TFFP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TFFP Stock Alerts